BPI
BIIB icon

BFC Planning, Inc.’s Biogen BIIB Stock Holding History

BFC Planning, Inc.’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.9K Buy
120
+9
+8% +$1.72K ﹤0.01% 1884
2026
Q1 		$20.3K Sell
111
-9
-8% -$1.66K ﹤0.01% 1705
2025
Q4 		$21.1K Hold
120
– – ﹤0.01% 1734
2025
Q3 		$16.8K Sell
120
-20
-14% -$2.7K ﹤0.01% 1667
2025
Q2 		$17.6K Sell
140
-452
-76% -$56.3K ﹤0.01% 1548
2025
Q1 		$81K Buy
592
+99
+20% +$14.2K 0.01% 937
2024
Q4 		$75.4K Buy
+493
New +$83.2K 0.01% 967

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BFC Planning, Inc.'s BIIB Position: Q2 2026 in Review

BFC Planning, Inc. increased its Biogen (BIIB) stake by 8.1% in Q2 2026, buying an estimated $1.72K and bringing the position to 120 shares worth $25.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1884.

BFC Planning, Inc. first reported a position in BIIB in Q4 2024 and has held it in 7 quarters since. The position peaked at $81K in Q1 2025. 1,048 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • BFC Planning, Inc. held 120 shares of Biogen worth $25.9K as of Q2 2026.
  • BFC Planning, Inc. bought 9 Biogen shares in Q2 2026, an estimated $1.72K.
  • Biogen made up ﹤0.01% of BFC Planning, Inc.'s portfolio in Q2 2026, its #1884 holding.
  • BFC Planning, Inc. first reported a position in Biogen in Q4 2024 and has held it in 7 quarters since.
  • BFC Planning, Inc.'s Biogen position peaked at $81K in Q1 2025.
  • 1,048 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on BFC Planning, Inc.'s 13F filing for Q2 2026, filed 29 Oct 2026.